Rana, M., Jensen, A., Velayati, A., Hovanky, V., Muffly, L., Sahaf, B., Iberri, D., Liedtke, M., Bharadwaj, S., Kennedy, V., Arai, S., Shiraz, P., Weng, W., Smith, M., Frank, M., Miklos, D., Dahiya, S., Hosoya, H., Mikkilineni, L., Sidana, S. (2025). Non-response to bridging therapy prior to CAR-T is associated with increased toxicity and adverse outcomes in Relapsed/Refractory multiple myeloma (RRMM). Blood. https://doi.org/10.1182/blood-2025-4586